ICI 182780 in Treating Women With Metastatic Breast Cancer
Study Information
Alliance Study ID: NCCTG-N0032
NCT Study ID (ClinicalTrials.gov): NCT00012025
Alliance Committee: Breast Cancer
Disease or Cancer Type: Breast Cancer
Alliance Study Chair: James N. Ingle, MD
Status: COMPLETED
Study Description
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using ICI 182780 may fight breast cancer by blocking the activity of estrogen in the tumor cells.
PURPOSE: Phase II trial to study the effectiveness of ICI 182780 in treating patients who have metastatic breast cancer that has not responded to previous hormone therapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information